Sanofi to pay $25M to resolve FCPA violations

The SEC on Tuesday announced that Paris-based pharmaceutical company Sanofi has agreed to pay more than $25 million to resolve charges that its Kazakhstan and Middle East subsidiaries made corrupt payments to win business.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.